Doximity, Inc. (NASDAQ:DOCS) Shares Purchased by QSV Equity Investors LLC

QSV Equity Investors LLC raised its position in Doximity, Inc. (NASDAQ:DOCS) by 0.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 60,763 shares of the company’s stock after purchasing an additional 186 shares during the quarter. Doximity comprises 3.1% of QSV Equity Investors LLC’s investment portfolio, making the stock its biggest position. QSV Equity Investors LLC’s holdings in Doximity were worth $3,244,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in DOCS. Global Retirement Partners LLC grew its position in Doximity by 468.1% in the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock worth $29,000 after acquiring an additional 440 shares during the period. UMB Bank n.a. raised its stake in shares of Doximity by 69.1% in the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after acquiring an additional 235 shares during the period. Larson Financial Group LLC lifted its holdings in shares of Doximity by 49.4% in the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock worth $40,000 after acquiring an additional 250 shares during the last quarter. Optimum Investment Advisors acquired a new stake in Doximity in the 4th quarter valued at approximately $43,000. Finally, Morse Asset Management Inc purchased a new stake in Doximity in the third quarter valued at approximately $46,000. Institutional investors and hedge funds own 87.19% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on DOCS shares. Stephens initiated coverage on Doximity in a research report on Friday, December 20th. They set an “equal weight” rating and a $55.00 price target for the company. Needham & Company LLC lifted their target price on Doximity from $65.00 to $82.00 and gave the company a “buy” rating in a report on Friday, February 7th. Bank of America increased their price target on Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a research report on Monday, January 6th. Wells Fargo & Company reissued an “equal weight” rating on shares of Doximity in a research report on Friday, February 7th. Finally, Raymond James reaffirmed an “outperform” rating and issued a $83.00 target price (up previously from $65.00) on shares of Doximity in a report on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $64.22.

Insider Buying and Selling

In related news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the sale, the director now directly owns 6,360 shares of the company’s stock, valued at approximately $366,463.20. This represents a 75.87 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 37.40% of the stock is currently owned by insiders.

Doximity Trading Down 3.6 %

DOCS stock opened at $58.40 on Friday. The firm has a 50 day moving average of $65.48 and a 200-day moving average of $54.30. The company has a market cap of $10.90 billion, a price-to-earnings ratio of 58.40, a PEG ratio of 4.10 and a beta of 1.34. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $85.21.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.